Paul Tudor Jones's ORGO Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 63,580 shares of Organogenesis Holdings Inc. (ORGO) worth $150,685, representing 0.00% of the portfolio. First purchased in 2019-Q4, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in ORGO, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 64,321 shares. Largest reduction occurred in Q3 2024, reducing 60,809 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Organogenesis Holdings (ORGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Organogenesis Holdings (ORGO) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +63,580 | New Buy | 63,580 | $2.37 |
| Q3 2025 | -15,525 | Sold Out | 0 | $0.00 |
| Q2 2025 | -25,053 | Reduce 61.74% | 15,525 | $3.66 |
| Q1 2025 | -23,743 | Reduce 36.91% | 40,578 | $4.32 |
| Q4 2024 | +64,321 | New Buy | 64,321 | $3.20 |
| Q3 2024 | -60,809 | Sold Out | 0 | $0.00 |
| Q2 2024 | -3,504 | Reduce 5.45% | 60,809 | $2.80 |
| Q1 2024 | -83 | Reduce 0.13% | 64,313 | $2.84 |
| Q4 2023 | +24,785 | Add 62.57% | 64,396 | $4.09 |
| Q3 2023 | -24,721 | Reduce 38.43% | 39,611 | $3.18 |
| Q2 2023 | +39,171 | Add 155.68% | 64,332 | $3.32 |
| Q1 2023 | +25,161 | New Buy | 25,161 | $0.00 |
| Q3 2022 | -21,572 | Sold Out | 0 | $0.00 |
| Q2 2022 | +21,572 | New Buy | 21,572 | $4.87 |
| Q1 2020 | -15,000 | Sold Out | 0 | $0.00 |
| Q4 2019 | +15,000 | New Buy | 15,000 | $4.80 |
Paul Tudor Jones's Organogenesis Holdings Investment FAQs
Paul Tudor Jones first purchased Organogenesis Holdings Inc. (ORGO) in Q4 2019, acquiring 15,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Organogenesis Holdings Inc. (ORGO) for 16 quarters since Q4 2019.
Paul Tudor Jones's largest addition to Organogenesis Holdings Inc. (ORGO) was in Q4 2024, adding 64,321 shares worth $205,827.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 63,580 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $150,685.
As of the Q1 2026 filing, Organogenesis Holdings Inc. (ORGO) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Organogenesis Holdings Inc. (ORGO) was 64,396 shares, as reported at the end of Q4 2023.